Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join Olink users, consortia, events and webinars to share insights and accelerate biomarker discovery.
Comprehensive statistical analysis & data visualization tools
Over 4,000 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
Molecular Cancer Therapeutics, 2015The Tyrosine Kinase Inhibitors Imatinib and Dasatinib Reduce Myeloid Suppressor Cells and Release Effector Lymphocyte Responses
Christiansson L., Söderlund S., Mangsbo S. et al.
Olink Target 96
Frontiers in Neurology, 2014Cerebral Microdialysis for Protein Biomarker Monitoring in the Neurointensive Care Setting – A Technical Approach
Hillered L., Dahlin A., Clausen F. et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2014High Plasma Levels of Heparin-Binding Epidermal Growth Factor Are Associated With a More Stable Plaque Phenotype and Reduced Incidence of Coronary Events
Rattik S., Wigren M., Björkbacka H. et al.
Brain, Behavior, and Immunity, 2014Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment
Isgren A., Jakobsson J., Pålsson E. et al.
International Orthopaedics, 2014Exogenous BMP7 corrects plasma iron overload and bone loss in Bmp6-/- mice
Pauk M., Grgurevic L., Brkljacic J. et al.
Nature Communications, 2014Strong effects of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs
Enroth S., Johansson ?., Enroth S. et al.
PLoS ONE, 2014Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability
Assarsson E., Lundberg M., Holmquist G. et al.
PROTEOMICS, 2014Antibody‐based proteomics and biomarker research—Current status and limitations
Solier C., Langen H.
4488 publications
Items per page
4481-4488 of 4488 publications